ELEVAR Trademark

Trademark Overview

On Monday, September 16, 2019, a trademark application was filed for ELEVAR with the United States Patent and Trademark Office. The USPTO has given the ELEVAR trademark a serial number of 88618601. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 15, 2024. This trademark is owned by Elevar Therapeutics, Inc.. The ELEVAR trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:

Novel cancer therapies, namely, pharmaceutical preparations and substances for the treatment of cancer

Information services, namely, providing consumer product information for medical professionals in the field of cancer and cancer treatment via a global computer network

Medical and scientific research; conducting clinical trials for others in the field of cancer therapeutics, distributed primarily to healthcare professionals; research and development in the field of cancer treatments
elevar

General Information

Serial Number88618601
Word MarkELEVAR
Filing DateMonday, September 16, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 13, 2021

Trademark Statements

Description of MarkThe mark consists of the stylized blue lowercase wording "ELEVAR". Above the letters "A" and "R" is the stylized design of wings in the gradient colors of blue, light blue and dark blue depicting a bird.
Goods and ServicesNovel cancer therapies, namely, pharmaceutical preparations and substances for the treatment of cancer
Indication of Colors claimedThe color(s) blue, light blue and dark blue is/are claimed as a feature of the mark.
Goods and ServicesInformation services, namely, providing consumer product information for medical professionals in the field of cancer and cancer treatment via a global computer network
Translation of Words in MarkThe English translation of the word "ELEVAR" in the mark is "to raise".
Goods and ServicesMedical and scientific research; conducting clinical trials for others in the field of cancer therapeutics, distributed primarily to healthcare professionals; research and development in the field of cancer treatments

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 25, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, September 25, 2019
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 25, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameElevar Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84121
Party NameElevar Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84121

Trademark Events

Event DateEvent Description
Thursday, September 19, 2019NEW APPLICATION ENTERED
Wednesday, September 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 26, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, November 12, 2019ASSIGNED TO EXAMINER
Friday, November 15, 2019NON-FINAL ACTION WRITTEN
Friday, November 15, 2019NON-FINAL ACTION E-MAILED
Friday, November 15, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 15, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 21, 2020ASSIGNED TO LIE
Thursday, May 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 21, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 16, 2020FINAL REFUSAL WRITTEN
Tuesday, June 16, 2020FINAL REFUSAL E-MAILED
Tuesday, June 16, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, December 16, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, December 17, 2020EXPARTE APPEAL RECEIVED AT TTAB
Thursday, December 17, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, December 17, 2020EX PARTE APPEAL-INSTITUTED
Friday, December 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 18, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 19, 2021NON-FINAL ACTION WRITTEN
Tuesday, January 19, 2021NON-FINAL ACTION E-MAILED
Tuesday, January 19, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 10, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 13, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 8, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 23, 2021EXPARTE APPEAL TERMINATED
Wednesday, December 8, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, December 8, 2021SOU EXTENSION 1 FILED
Wednesday, December 8, 2021SOU EXTENSION 1 GRANTED
Friday, December 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 8, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, June 8, 2022SOU EXTENSION 2 FILED
Wednesday, June 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 15, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 16, 2022SOU EXTENSION 2 GRANTED
Friday, June 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 8, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 8, 2022SOU EXTENSION 3 FILED
Thursday, December 8, 2022SOU EXTENSION 3 GRANTED
Saturday, December 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 8, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 8, 2023SOU EXTENSION 4 FILED
Thursday, June 8, 2023SOU EXTENSION 4 GRANTED
Saturday, June 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 5, 2023SOU EXTENSION 5 FILED
Monday, December 11, 2023SOU EXTENSION 5 GRANTED
Tuesday, December 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 15, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 15, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

elevar cancer field treatment information professionals medical namely research trials clinical